SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Chan Hum Park, M.D., Ph.D., Professor of Otolaryngology at Hallym University Chuncheon Sacred Heart Hospital and Director of the Nano-Bio Regenerative Medical Institute at Hallym University, leads the research team whose space biology payload, BioCabinet, will launch aboard the Nuri rocket's fourth flight on November 27, as part of the mission carrying the Next-Generation Medium Satellite-3.
BioCabinet is a research platform with a bio 3D printer and stem cell differentiation incubator. Designed to fabricate artificial heart tissue and evaluate disease responses in space, it will operate for 60 days, extendable up to one year.
BioCabinet to 3D-Print Heart Tissue in Space
The payload has two modules: the first observes beating and contraction of cardiac tissue 3D-printed from induced pluripotent stem cell–derived cardiomyocytes; the second evaluates blood vessel differentiation using tonsil-derived stem cells, ideal for terrestrial and space studies.
BioCabinet is expected to generate core data for organ fabrication and cardiovascular research in space, marking South Korea's first acquisition of biological tissue data under environmental variables such as pressure, temperature, and radiation.
Beyond Terrestrial Limits, Seeking Answers in Space
Space research overcomes Earth-bound limits, where gravity hinders 3D tissue formation. In microgravity, cells grow naturally into 3D structures, and drug crystallization improves, enabling high-purity anticancer compound production. Artificial heart-beating data from this study will aid cardiovascular drug development.
From BioCabinet to BioRexs, to BioLiv… The Challenge Continues
Professor Park is expanding space bioengineering research based on the BioCabinet platform. He is developing BioRexs, a drug-screening platform slated for launch in 2027 to culture glioblastoma in space and evaluate anticancer drug efficacy. In parallel, he is leading the BioLiv project, which aims to 3D-print and culture artificial liver tissue in space and return it to Earth for transplantation. This is expected to become the world's first non-clinical study using a space-fabricated artificial organ.
In addition, follow-up space bioengineering projects such as BioFactory, BioDeep, BioLunar, and BioMars are also underway.
Professor Park emphasized the importance of national investment, stating, "Conducting research in outer space is not about pursuing short-term profit—it is about creating technologies that shape the future." This mission represents Korea's first step into space-based bioengineering, establishing the nation's foundation for biological tissue 3D printing research and verifying stem cell survival and cardiac tissue formation in the space environment.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Professor Chan Heum Park's Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed "BioCabinet" to Space Aboard Nuri Rocket
PUNE, India, April 2, 2026 /PRNewswire/ -- EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company's comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.
"FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.
India's transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition."
— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility
Strong Business Momentum Across Segments
- Electric Bus Leadership:
Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi - SCV Breakout Year:
Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption - Electric Trucks:
New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification - Hydrogen Fuel Cell:
Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses
Key Highlights:
Global Expansion:
- Commenced electric bus deployments in Africa
- Partnership with Kerchanshe Group for CKD assembly and distribution
- Agreement with NBFI Capital for manufacturing in Australia
Manufacturing Scale-Up:
- Two Pune facilities operational; Pithampur plant to be operational shortly
- Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs
Retail Network:
- Expanded dealership network; plans to add 120 dealerships in FY27
Order Book Visibility:
- 6,000+ confirmed e-buses to be delivered over the next two years
About EKA Mobility
EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India's commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.
EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.
To know more about the company, kindly visit: https://ekamobility.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
EKA Mobility Achieves 5x Volume Growth
